Enzymatica Plots Entry To North America And Asia

The Swedish firm is plotting the path towards launching its ColdZyme virus-blocking spray in China and Japan, while efforts are also underway to find a partner for the North American market.

Business_Finance_Meeting
• Source: Shutterstock

More from Strategy

More from Earnings